Terrence Higgins Trust uses cookies to improve your experience of our websites. For more information or to change the use of cookies, please click here.

Accept and Close

Evotaz (atazanavir + cobicistat)


Generic name: atazanavir and cobicistat

Brand names: Evotaz

Class: Combined PI (protease inhibitor) tablets


Common: jaundice (yellowing of the skin and/or eyes), nausea, high blood sugar, increased appetite, change in sense of taste, dry mouth, headache, dizziness, insomnia (difficulty sleeping), abnormal dreams, sleepiness, vomiting, diarrhoea, abdominal pain, indigestion, bloating, flatulence, hyperbilirubinaemia (raised bilirubin levels in the blood), rash, lipodistrophy, fatigue.

Rare: irregular heartbeat, allergic reaction, diabetes, depression, peripheral neuropathy, liver problems, kidney problems, gallbladder problems, chest pain.


Tablet comprising 300mg atazanavir and 150mg cobicistat. Cobicistat is a booster drug, which boosts the effect of atazanavir.

Take one tablet a day.


Take with food.

*Last reviewed on 03/10/2015 Next review: 03/10/2018

Any questions? Email feedback@tht.org.uk Information included on this website was correct at the time of publication.

Data and image supplied by NAM.

Further information on this drug from NAM